Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviTransition to the IDEA platform
On June 4th, Hepatitis C Online will be joining the Infectious Diseases Education and Assessment (IDEA) platform.
Learn more about the IDEA platform at https://idea.medicine.uw.edu.
This will bring the following new functionality and benefits:
- Your Hepatitis C Online account will become an IDEA account
- Your new IDEA account will work on all websites on the IDEA platform (currently this is the Hepatitis C Online, the National HIV Curriculum, and the National STD Curriculum)
- An IDEA account will require verification of your e-mail address
- Groups will no longer require approval by our team, and an unlimited number of them can be created
- Groups will have extra roles: Learner, Manager, Evaluator and Owner
- Groups can be joined with Add Codes (rather than just e-mail invitations)
- Groups will have a logo, a description, and instructions for Learners
The Hepatitis C Online is now part of the Infectious Diseases Education & Assessment (IDEA) platform.
Your Hepatitis C Online account will work for all websites on the IDEA platform:
